Navigation Links
Thomson Reuters Announces 2009 Edition of the CMR International Pharmaceutical R&D Factbook
Date:7/22/2009

PHILADELPHIA and LONDON, July 22 /PRNewswire/ -- The 2009 edition of the trusted and often cited compendium of pharmaceutical research and development statistics, the CMR International Pharmaceutical R&D Factbook, is now available. This year's Factbook offers extended content including patent information and emerging trends in worldwide pharmaceutical R&D.

"The R&D Factbook provides the data that R&D companies need to make informed decisions," said Dr. Jane Sharples, General Manager of CMR International. "With this publication, R&D companies can gain insights into industry dynamics and trends, determine how they perform against the market as a whole and gauge their productivity in relation to their peers and competitors. Companies can also see the consequences of adopting different R&D strategies. In short, they have accurate, independent and validated information on which to base business decisions."

Highlights of the 2009 edition include:

  • The number of new molecular entities (NME) launched onto the global market failed to improve on 2008's 20-year low. Actual development times for new molecular entities are slowly increasing to 14 years, though major pharmaceutical companies (those that spent more than $2 billion on R&D in 2008) take on average slightly more than 11 years.
  • Anti-cancer therapy is the most common area for new patent filing on emerging targets.
  • India leads the way in the recent trend towards new molecular entity research by generic specialty companies.

The Centre for Medicines Research International Ltd (CMR International), a Thomson Reuters business, yearly publishes the Factbook. This is an up-to-date business planning tool for decision makers in the pharmaceutical industry, including R&D, corporate finance, business strategy, marketing pla
'/>"/>

SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
2. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
3. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
4. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
5. Thomson Scientific Begins Expansion of Web of Science
6. Thomson Reuters Launches New Biomarkers Solution
7. The Scientific Business of Thomson Reuters Publishes Its 2008 Liquent Regulatory Affairs Trends Survey Results
8. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
9. Despite Decline in Share of Global Output, U.S. Science Impact Still Strong, Says Thomson Reuters
10. Thomson Reuters Names Hottest Researchers and Papers of 2007-2008
11. APS Healthcare and Thomson Reuters to Manage New York States Medicaid Clinical Best Practices Review Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Pittcon Organizing Committee is pleased ... Safety Tech , an e-Journal and producer of ... the second year for the co-location of Food Labs Conference ... provides that the registration fee to attend the two-day Food ...
(Date:1/15/2014)... SAN JOSE, California , January 15, 2014 ... antibody-drug conjugates for cancer, today announced the appointment of Thomas ... Reynolds has over 20 years, development experience gained in the ... Genetics. "I am delighted to welcome Tom at ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 More than ... and about 1 in 3 seniors will die with ... ). These jaw-dropping figures have shocked many Americans into ... hopefully, help prevent these tragic age-related cognitive disorders. Jonathan ...
(Date:1/15/2014)... January 15, 2014 2013 was a ... Brain State Technologies®. They saw continued independent research led ... who were awarded a $1 million grant from the ... “Brain and Behavior” a peer reviewed journal, Amy Grant ...
Breaking Biology Technology:Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3
... increasing global demand for health ... economics and market access support, BOSTON, Oct. ... Adam Barak as Vice President., Mr. Barak brings 16 ... pricing and reimbursement strategies,for drugs, medical devices, and diagnostics in ...
... Also Announces Completion of Enrollment in U.S. Phase ... Hepatitis C,Genotype 1, TAMPA, Fla., Oct. 28 ... announced the presentation of studies,of nitazoxanide at the ... the Study of Liver Diseases (AASLD), also known ...
... - Laureate To Manufacture Tolera,s Monoclonal Antibody ... 28 Laureate Pharma, Inc., a,full-service biopharmaceutical ... it has entered into a cGMP contract ... company that,develops and offers targeted therapies and ...
Cached Biology Technology:Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement Capability 2Romark Laboratories Announces Presentation of New Nitazoxanide Data at 59th Annual AASLD Meeting and 50th Anniversary IASL Meeting in San Francisco 2Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc. 2
(Date:4/20/2014)... for both basic researchers and medical practitioners, researchers ... Maryland have developed a new computational method that ... RNA sequencing (RNA-seq) data., With the new method, ... of gene expression that previously took many hours ... accuracy that equals or exceeds previous methods. The ...
(Date:4/18/2014)... A survey of emergency contraceptive pills in Peru ... were either of substandard quality or falsified. Many ... had the wrong active ingredient. One batch had ... detect the fake drugs, researchers at the Georgia ... mass spectrometry to quickly assess suspected counterfeit drugs ...
(Date:4/18/2014)... as they,re planted may be good news for a garden. ... wild, a plant whose seeds sprouted at the first ,warm ... an insurance policy against late frosts or unexpected dry spells, ... Plants whose seeds put off sprouting until conditions are ... team of researchers working at the National Evolutionary Synthesis Center ...
Breaking Biology News(10 mins):Computational method dramatically speeds up estimates of gene expression 2Counterfeit contraceptives found in South America 2Counterfeit contraceptives found in South America 3Plants with dormant seeds give rise to more species 2
... belonging to the genus Daphniola was found by a ... spring covered by snow on Mt. Parnassos, central Greece. This study ... . The new species, Daphniola eptalophos , ... a black penis with a small colorless outgrowth on the left ...
... Acinetobacter baumannii (MDR-AB) was found in the ... colonized or infected with the pathogen, according to a ... American Journal of Infection Control , the official ... Infection Control and Epidemiology. The study examined ...
... of Southern California (USC) professor Mary Ann Pentz, Ph.D., shows ... are more likely to drink alcohol in high school than ... September-October 2011 issue of the journal Alcohol and Alcoholism ... that may benefit from special prevention programs. "As you ...
Cached Biology News:Acinetobacter baumannii found growing in nearly half of infected patient rooms 2Underage drinking among close friends high indicator of future alcohol use by black teens 2
Recombinant Rhesus Monkey IFN-Alpha...
Homo sapiens HCLS1 associated protein X-1 Antigen: Recombinant Protein...
5,6 Carboxyfluorescein is conjugated to BSA (bovine serum albumin) protein through amide bonds....
MOUSE ANTI BOVINE WC1:FITC Immunogen: Bovine lymphocytes...
Biology Products: